Email Updates

Search form

You are here

Webinar & Meeting Reports

  • September 5, 2017

    On September 5, there was a conversation with Dr. Carl Dieffenbach, the Director of the Division of AIDS (DAIDS) at the NIH’s National Institute of Allergy and Infectious Diseases, about the future of investments in the US National Institutes of Health’s (NIH) HIV clinical trial research networks in the US and internationally.

    Every seven years, the NIH reviews the structure and funding of its HIV clinical research networks. This “network recompetition” process involves decisions will help determine the focus and priorities of its HIV clinical trial networks through 2027, as well as the number and structures of the various networks that undertake this research. These are critical questions for advocates to weigh in on—whether you are in the US or not.

    The webinar included a brief introductory presentation from Dr. Carl Dieffenbach followed by a Q&A session. NIAID is also currently accepting public comments and questions online, so now is your chance!

    Recording: YouTube / Audio / Slides

  • August 21, 2017

    This IRMA/AVAC teleconference featured Dr. Jose Bauermeister (University of Pennsylvania), Dr. Craig Hendrix (Johns Hopkins) and Dr. Kenneth Palmer (University of Louisville) who presented their promising new rectal microbicide research that is underway — we have new molecules, new formulations, new platforms for delivery and new acceptability explorations. Very exciting stuff!

    On August 7, we glanced back at where we have been on this long and winding rectal road. On August 21, we looked to where we are going - where we need to go. It is this momentum we want to sustain. And it is the promise of a safe, effective, acceptable/desirable and accessible rectal microbicide for which we must fight — the future is not promised.

    Recording: YouTube / Audio / Slides

  • August 7, 2017

    IRMA's Marc-Andre LeBlanc and Craig Hendrix of Johns Hopkins and the Microbicide Trials Network provide a rollicking rectal recap. From the rectal dawn of research and advocacy til today, scientists and advocates have worked together tirelessly (and fiercely) to advance safe, effective, acceptable and accessible rectal microbicides for the men, women, and transgender individuals who want and need them.

    With threats to the microbicide field at large coming from multiple angles, this webinar takes stock of where we have been and where we are now in terms of rectal microbicide research and advocacy to help us chart our collective course forward. We seek to ensure adequate, sustainted resources for the development of user-desired, user-initiated, short-term, non-systemic, pleasure-enancing HIV prevention options - including rectal microbicides.

    Recording: Youtube / Audio / Slides

  • July 23, 2017 to July 26, 2017

    The IAS 2017 conference took place between July 23–26 in Paris. Read on for details on AVAC satellite sessions, data to watch for and a prevention roadmap

    Held every two years, this year’s conference included results from several HIV prevention trials, including data from HPTN’s Phase II long-acting injectable PrEP trial as well as Janssen’s Phase II vaccine trial, important findings from PrEP clinical trials, initial evidence of impact on confronting the epidemic in Swaziland, and more!

    The full conference schedule is available on the conference website, and AVAC has pulled together an HIV prevention roadmap, sortable by timing, intervention and session type (also available as a PDF). The conference organizers have also engaged with partners to create additional roadmaps, which viewable here.

    Following on the Web

    • In addition to AVAC’s online commentary on Twitter and Facebook, you could follow the official conference hashtag—#IAS2017.
    • Aidsmap was the official scientific news reporter for IAS 2017 and regularly updated its IAS 2017 page. Check it out here.
    • FHI 360 was an official media sponsor and hosted a digital live coverage hub for IAS 2017 on its Crowd 360 platform.
    • IAS Live debuted this year with IAS 2017 offering access to live streaming of the opening and closing sessions as well as the plenary sessions and press conferences. All session content is available through the online programme.

    Satellite Sessions

    Here are details on two satellite sessions that AVAC and partners are organized:

    The Next Wave of Prevention Options: An update and interactive discussion on the pipeline of injections, infusions and implants—who will use, who will deliver, who will pay
    Sunday, 23 July — Maillot Room
    (Download flyer)

    Advocates, researchers and implementers, including Ambassador Deborah Birx, discussed HIV prevention R&D—what potential users want from the next wave of prevention options, what’s scientifically feasible, what trials might look like, the development pathways and how to work together to accelerate progress.

    Future Perfect: Opportunities and Obstacles for HIV Vaccines
    Sunday, 23 July — Maillot Room
    (Download flyer)

    This satellite featured three state-of-the-art presentations on the vaccine pipeline, including passive immunization, promising vector-platforms, and the development of envelope proteins able to elicit broadly neutralizing antibodies.

  • June 14, 2017

    Where: Senate Hart Office Building – Room 902
    When: Noon − 5pm
    Additional details: Lunch will be served

    To RSVP, click here.

    For information, contact AIDSSummit@hayespr.com or 571-286-5950.

    Topics will include HIV/AIDS and the opioid epidemic, aging with HIV/AIDS, the national security implications of epidemics, and the need for cutting-edge research and services to end the HIV/AIDS epidemic.

    Speakers include:

    • Ambassador Deborah Birx
      Global AIDS Coordinator, US Department of State
    • Susan J. Blumenthal, MD, MPA
      Senior Policy and Medical Advisor, amfAR
      Former US Assistant Surgeon General
    • Michael Botticelli
      Director, Grayken Center for Addiction Medicine, Boston University Medical Center
      Former Director, White House Office of National Drug Control Policy
    • Kenneth Cole
      Chairman of the Board, amfAR
    • Tony Fauci, MD
      Director, National Institute of Allergy and Infectious Diseases, NIH
    • Maureen Goodenow, PhD
      Director, Office of AIDS Research, National Institutes of Health
    • Ron Klain
      Former White House Ebola Response Coordinator
      Executive Vice President, Revolution
    • Holly Kuzmich
      Executive Director, The Bush Institute
    • Jonathan Mermin, MD, MPH
      Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
      Centers for Disease Control and Prevention (CDC)
    • Michel Sidibé
      Executive Director, UNAIDS
      Under-Secretary-General, United Nations
    • Judy Woodruff, Moderator
      Anchor and Managing Editor, PBS Newshour
  • June 14, 2017 to June 16, 2017

    From the conference website:
    Changing Faces, Changing Spaces is a Pan African Conference that brings together human rights activists and organizations, health and legal professionals, allies and donor partners from across Africa and beyond, undertaking and supporting African sex worker and LGBTIGNC activism. We deliberate, strategize and share the experiences that impact our movements. It is unique in the sense that it is a conference conceptualized and planned by a task force comprised by activists from the LGBTI and sex worker movements in Africa.

    Click here for conference details.

  • June 13, 2017

    In this webinar, Jeff Taylor from the Care Collaboratory CAB at the University of North Carolina will discuss the basics needed to understand cure research and clinical trials, utilizing the CUREiculum, AVAC's cure education tool.

    Webinar objectives:

    • Define terms needed to understand cure research
    • Explore the major challenges to developing a cure
    • Understand the current state of cure research

    Register at http://bit.ly/cure101

  • June 13, 2017 to June 15, 2017

    The South African AIDS Conference (SA AIDS) took place June 13-15 at the International Convention Centre in Durban. SA AIDS is an energizing, biennial conference that brings together a cross-section of the people and organizations sustaining the HIV/AIDS movement in South Africa.

    This year’s theme, The Long Walk to Prevention: Every Voice Counts, comes at a critical time for HIV research and rollout in South Africa. In a time of both great uncertainty, but also of exciting dynamism in the prevention field, AVAC is thrilled to see the conference focusing on this essential component of a comprehensive AIDS response.

    We gathered a full roadmap of prevention research oriented events and presentations. Download our roadmap here, and the full conference program here.

    Key Sessions

    • Community Village — An interactive and participatory space to discuss cutting-edge issues in HIV, share knowledge and skills and network. Open to conference participants and to the general public.
    • Research Literacy Networking Zone — Wits RHI in partnership with AVAC, SAHTAC and APHA will disseminate research literacy materials and conduct fun and educational games focused on HIV prevention research R&D and advocacy. The zone will be located in the Women’s Networking Zone within the Community Village.
    • HIV Prevention and SRHR Masterclass
      Tuesday, June 13 – Thursday, June 15, 7:00 – 8:30 — Hosted by the African Alliance for HIV prevention at the Hilton Hotel.
    • Satellite Session: PrEP (sponsored by Gilead)
      Tuesday, June 13, 11:30 – 13:00 — Located in Hall 8b.
    • Up Your Game: Play to Learn About HIV Prevention and Research
      Tuesday, June 13, 12:00 – 13:00 — An HIV prevention research literacy game hosted on the main stage in the Community Village by AVAC, WRHI, SAHTAC and APHA.
    • Dapivirine Ring Licensure Program
      Tuesday, 13 June, 18:00 – 20:00 — This interactive satellite session, hosted by IPM, will showcase the developments in the dapivirine vaginal ring program. Located in Hall 5.
    • Basic Science: Putting the spanner in the works – the nuts and bolts of HIV prevention
      Wednesday, June 14, 9:00 – 11:00 — A roundtable plenary discussion with leading scientists. Located in Hall 1.
    • Improving HIV prevention by investing in research and development and services
      Wednesday, June 14, 11:30 – 13:00 — This workshop will provide health advocates and technical experts from the HIV prevention sector a platform to share ideas on how to improve implementation of R&D policies, and streamline regulatory processes that support the development, introduction and scale of high-impact health technologies in South Africa. Located in Hall 10.
    • Contraception and HIV: What they say, what we hear, what needs to change — a young women's dialogue
      Wednesday, June 14, 18:00 – 20:00 — A roundtable dialogue with young advocates. Located in the Women's Networking Zone.

    AVAC posted live updates from the conference on our Facebook and Twitter pages. Blogs were posted on the WhatsUpHIV blog. The conference was on Twitter at @SAAIDS2017 and used the hashtag #SAAIDS2017.

  • May 23, 2017 to May 25, 2017

    For more information, including the At-A-Glance and full program, click here.

    Where:
    Omni Shoreham Hotel
    2500 Calvert Street NW
    Washington, DC 20008

  • May 18, 2017

    Lieutenant Colonel Julie Ake, Principal Deputy Director of the US Military HIV Research Program (MHRP), wraps up our HVAD webinar series by providing an overview of MHRP’s HIV program and helping to connect dots in the HIV vaccine field.

    Ake takes us through the landmark RV144 trial, the first HIV vaccine trial to show efficacy, and gives a clear and compelling update on where HIV vaccine research is and where it needs to go to ensure the development of a safe and effective vaccine. She also provides insight into the linkages to HIV treatment and cure research, as well as other vaccine development efforts, illuminating in particular the ways in which HIV vaccine research has informed Ebola and Zika vaccine development.

    This was the fifth in our series of HIV Vaccine Awareness Day webinars. For details on the full series, visit avac.org/hvad.

    Recording: YouTube / Audio / Slides

Pages